Journal Home
Search for

Volume 36, Issue 4, Pages 367-373 (October 2008)


View previous. 10 of 16 View next.

Psychometric Properties of the Brief Fatigue Inventory in Greek Patients with Advanced Cancer

Kyriaki Mystakidou, MD, PhDaCorresponding Author Informationemail address, Eleni Tsilika, BSc, MSca, Efi Parpa, BA, MAa, Tito R. Mendoza, PhDc, Kyriaki Pistevou-Gombaki, MD, PhDd, Lambros Vlahos, MD, PhDb, Charles S. Cleeland, MD, PhDc

Accepted 1 November 2007. published online 28 April 2008.

Abstract 

To validate the Greek version of the Brief Fatigue Inventory (BFI-Gr) in a sample of cancer patients, the scale was translated with the “forward–backward” procedure to Greek. It was administered twice, at a three-day interval, to 102 eligible patients with cancer. Together with the BFI-Gr scale, the patients also completed the European Organization for Research and Treatment of Cancer QLQ-C30 (version 3.0) subscales of fatigue and emotional functioning, and the M. D. Anderson Symptom Inventory. The BFI-Gr had an overall Cronbach alpha for the nine items of 0.954. The assessment of the relationships between the BFI-Gr and the other measurements showed statistically significant correlations between all the assessed measurements (r values between 0.47 and 0.76, P<0.0005), except with the emotional subscale of the European Organization for Research and Treatment of Cancer scale. Factor analysis yielded a one-factor solution, explaining 73.6% of the variance. Interitem correlations were high and ranged from 0.567 to 0.882 (P<0.0005). The test–retest reliability of scale showed that the coefficient agreement was 0.901 (P<0.0005). Univariate analysis revealed significant correlations between hemoglobin and fatigue (r=−0.21, P=0.037), and between performance status (P<0.0005) and opioids (P=0.009). These results support that the BFI-Gr is an instrument with satisfactory psychometric properties, and is a valid research tool for cancer-related fatigue in Greek cancer patients

a Pain Relief and Palliative Care Unit, Areteion Hospital, School of Medicine, University of Athens, Athens, Greece

b Department of Radiology, Areteion Hospital, School of Medicine, University of Athens, Athens, Greece

c Pain Research Group, University of Texas, M. D. Anderson Cancer Center, Houston, Texas, USA

d Radiotherapy Department, University of Thessaloniki, Thessaloniki, Greece

Corresponding Author InformationAddress correspondence to: Kyriaki Mystakidou, MD, PhD, Pain Relief and Palliative Care Unit, Department of Radiology, Areteion Hospital, School of Medicine, University of Athens, 27 Korinthias Street, 115 26 Athens, Greece.

PII: S0885-3924(08)00148-6

doi:10.1016/j.jpainsymman.2007.10.021


View previous. 10 of 16 View next.